Erlotinib vs Levopropoxyphene
Erlotinib vs Levopropoxyphene: Overview
This comparison examines the pharmacological differences between Erlotinib and Levopropoxyphene.
Mechanism of Action
Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.
Pharmacokinetics
Half-life: Erlotinib β 36 hours.
Chemical Properties
Molecular Formula: Erlotinib β C22H23N3O4.
Molecular Weight: Erlotinib β 393.4380 g/mol.
Type: Erlotinib β Small molecule; Levopropoxyphene β Small molecule.